Our Pricing

Buy Single Pen UK Weight Loss Injection

Published on: June 03, 2026

When you buy single pen UK weight loss injection treatments from Cured Pharmacy, you're accessing genuine UK-licensed medications with transparent upfront pricing and expert clinical support. Our range includes Mounjaro from £135.00 Wegovy from £135.00 and Saxenda from £135.00 all requiring a free online consultation with a UK-registered prescriber before dispensing.

Understanding Single Pen Weight Loss Injections in the UK

Single pen weight loss injections represent the latest generation of prescription treatments for obesity management in the UK. Each pre-filled pen contains a fixed amount of medication — typically enough for one month of treatment at maintenance doses — making them convenient for patients who prefer not to handle vials and syringes [1].

The MHRA has licensed three main injectable weight loss treatments available as single pens: tirzepatide (Mounjaro), semaglutide (Wegovy), and liraglutide (Saxenda). All three work by mimicking natural gut hormones called incretins, which regulate appetite and blood sugar levels [2]. Clinical trials have demonstrated that these medications, when combined with lifestyle changes, can help patients achieve significant weight reduction over 12-24 months [1][2].

At Cured Pharmacy, every weight loss injection requires clinical assessment by our UK-registered prescribers. This ensures the treatment is medically appropriate for your individual circumstances, including your BMI, medical history, and any contraindications that might affect safety or efficacy.

How Weight Loss Injection Pens Work

Weight loss injection pens deliver GLP-1 receptor agonists (or dual GIP/GLP-1 agonists in the case of Mounjaro) subcutaneously, typically into the abdomen, thigh, or upper arm. These medications work through multiple mechanisms: they slow gastric emptying, reduce appetite signals in the brain, and improve insulin sensitivity [3].

The pen format simplifies administration compared to traditional vial-and-syringe systems. Each pen comes pre-filled and pre-dosed, with a simple dial mechanism to select your prescribed dose. Most patients find the injection process quick and relatively painless after the first few attempts, with ultra-fine needles minimising discomfort [4].

Dosing schedules vary by medication. Mounjaro and Wegovy require once-weekly injections, whilst Saxenda is administered daily. Your prescriber will start you on a lower dose and gradually increase it over several weeks to minimise gastrointestinal side effects — a process called dose escalation that's standard across all GLP-1 treatments [3][4].

Injection Technique and Storage

Proper injection technique ensures optimal medication absorption and reduces the risk of injection site reactions. Before each injection, inspect the pen for clarity (the solution should be clear and colourless), select a new injection site at least 5cm away from your last injection, and allow the medication to reach room temperature if stored in the fridge.

All weight loss injection pens must be stored in a refrigerator between 2°C and 8°C before first use. Once in use, most pens can be stored at room temperature (below 30°C) for a specified period — typically 21-30 days depending on the medication. Never freeze these medications, and always dispose of used pens in a sharps container, which we can provide guidance on obtaining.

Comparing Single Pen Options: Mounjaro, Wegovy, and Saxenda

Mounjaro (tirzepatide) is the newest weight loss injection licensed in the UK and the only dual GIP/GLP-1 receptor agonist available. In the SURMOUNT-1 trial, patients taking the highest dose achieved an average weight reduction of 22.5% over 72 weeks — the highest efficacy demonstrated in any weight loss medication trial to date [1]. Each Mounjaro KwikPen contains four doses for once-weekly administration.

Wegovy (semaglutide) has been available in the UK since 2022 and works through GLP-1 receptor activation alone. The STEP clinical trial programme showed an average weight loss of 14.9% over 68 weeks at the 2.4mg maintenance dose [2]. Wegovy pens also deliver once-weekly injections, with a dose escalation schedule spanning 16-20 weeks before reaching the maintenance dose.

Saxenda (liraglutide) is a daily injection that's been licensed for weight management in the UK since 2015. Whilst it requires more frequent administration, some patients prefer the flexibility of daily dosing. Clinical trials demonstrated an average weight loss of 8-9% over 56 weeks, which is lower than the newer weekly options but still clinically significant for many patients [5].

Which Single Pen Is Right for You?

Your UK prescriber will recommend a specific treatment based on several factors: your BMI, weight loss goals, medical history, tolerance for injection frequency, and any contraindications. Patients with a history of pancreatitis, thyroid conditions, or severe gastrointestinal disease may not be suitable candidates for GLP-1 treatments.

Cost is another consideration. Whilst Mounjaro demonstrates the highest efficacy in clinical trials, it also carries a higher price point. Some patients achieve their goals with more affordable options like Saxenda or Wegovy. Your prescriber can help you balance clinical effectiveness with budget considerations during your consultation.

Expected Results and Timeline for Weight Loss Injections

Weight loss with injectable GLP-1 treatments occurs gradually over many months. Most patients notice reduced appetite within the first week of treatment, but measurable weight reduction typically becomes apparent after 4-8 weeks [3]. The dose escalation phase means you won't reach the full therapeutic dose immediately — this gradual increase helps your body adjust and minimises side effects.

Clinical trial data provides realistic expectations: patients using Mounjaro lost an average of 22.5% of their starting weight over 72 weeks, whilst Wegovy users lost 14.9% over 68 weeks, and Saxenda users lost 8-9% over 56 weeks [1][2][5]. Individual results vary significantly based on adherence to the medication, dietary changes, physical activity levels, and metabolic factors.

It's crucial to understand that these medications work best as part of a comprehensive weight management programme. NICE guidelines recommend combining injectable treatments with a reduced-calorie diet and increased physical activity [6]. Patients who make sustainable lifestyle changes alongside medication typically achieve better long-term results than those relying on medication alone.

Common Side Effects and How to Manage Them

Gastrointestinal side effects are the most common with all GLP-1 weight loss injections. Nausea, diarrhoea, constipation, and abdominal discomfort affect up to 40-50% of patients, particularly during dose escalation [3][4]. These effects usually diminish after several weeks as your body adjusts to the medication.

To minimise gastrointestinal symptoms, eat smaller, more frequent meals rather than large portions, avoid high-fat and spicy foods, stay well-hydrated, and take your time when eating. If nausea becomes severe or persists beyond the first month, contact your prescriber — they may adjust your dose escalation schedule or recommend anti-nausea strategies.

Serious side effects are rare but require immediate medical attention. These include severe abdominal pain that doesn't resolve (which could indicate pancreatitis), signs of thyroid tumours (neck lump, difficulty swallowing, persistent hoarseness), or symptoms of gallbladder problems [4]. Your prescriber will review these risks during your consultation and determine whether you have any predisposing factors.

When to Contact Your Prescriber

Contact your prescriber if you experience severe or persistent vomiting that prevents you from keeping fluids down, signs of dehydration, unexplained severe abdominal pain, changes in vision, or symptoms of low blood sugar (if you're taking other diabetes medications). Most side effects are manageable with simple strategies, but your clinical team at Cured Pharmacy is available to provide guidance whenever needed.

Regular follow-up is essential when using weight loss injections. Your prescriber will typically review your progress every 3-6 months to assess weight loss, side effects, and whether the treatment remains appropriate. If you haven't achieved at least 5% weight loss after 12 weeks at the maintenance dose, your prescriber may recommend discontinuing the medication and exploring alternative approaches.

Ordering Single Pen Weight Loss Injections from Cured Pharmacy

Purchasing weight loss injection pens from Cured Pharmacy begins with a free online consultation that takes under three minutes to complete. You'll answer questions about your medical history, current medications, weight loss goals, and any contraindications. Our UK-registered prescribers review every consultation individually — there's no automated approval system.

If your prescriber approves treatment, you'll receive a notification with your prescription details and final pricing. All our weight loss injections are genuine UK-licensed medications sourced directly from licensed wholesalers. We never supply unlicensed or compounded alternatives, ensuring you receive the same quality medication dispensed by high-street pharmacies.

Delivery is discreet and trackable, with most orders dispatched within 24-48 hours of prescription approval. Your medication arrives in plain, unmarked packaging with no external indication of contents. We use temperature-controlled packaging for injectable medications to maintain the cold chain required for GLP-1 treatments. As a GPhC-registered pharmacy (registration number 9012511), we're held to the same standards as any UK pharmacy, with superintendent pharmacist Tarun Kumar (GPhC 2233073) overseeing all clinical operations.

Scientific References

1. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
2. Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
3. Müller, T. D., Finan, B., Bloom, S. R., et al. (2019). Glucagon-like peptide 1 (GLP-1). Molecular Metabolism, 30, 72–130. https://doi.org/10.1016/j.molmet.2019.09.010 [accessed 13 August 2026]
4. Electronic Medicines Compendium. (2023). Mounjaro 2.5 mg solution for injection in pre-filled pen - Summary of Product Characteristics. Retrieved from https://www.medicines.org.uk/emc/product/14926 [accessed 13 August 2026]
5. Pi-Sunyer, X., Astrup, A., Fujioka, K., et al. (2015). A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. New England Journal of Medicine, 373(1), 11–22. https://doi.org/10.1056/NEJMoa1411892 [accessed 13 August 2026]
6. National Institute for Health and Care Excellence. (2023). Obesity: identification, assessment and management (CG189). Retrieved from https://www.nice.org.uk/guidance/cg189 [accessed 13 August 2026]
7. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
8. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
9. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Weight loss results vary between individuals and depend on adherence to treatment, dietary modifications, and lifestyle factors. Past clinical trial results do not guarantee individual outcomes.